Table of Contents
Even though the commercial introduction of a new generic formulation is perhaps always of significance, the approval of a therapeutic equivalent to Kadian® is especially notable because it is one of the most expensive long-acting narcotic medications on the market.
A schedule II controlled substance directed for moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period, Kadian® is available in a wide range of capsule potencies ranging from 10mg to 200mg. The AWPs for Kadian® go for between $5.26 and $42.24 per capsule.
There two points to keep in mind; first, long-acting opioid therapy is lifelong, and patients generally grow tolerant of the analgesic effects of opioids. Very often, this interprets into a potentially endless series of dosage increases for drugs like Kadian®.
Consequently, the potential cost savings for any workers’ compensation claimant is much more significant than the cost savings associated with the scenario above. Taking the potential for future dose increases into consideration. Secondly, at present, there are only two manufacturers of generic versions of Kadian®. As more generic manufacturers enter the market, the competition will force AWPs downward.
It is difficult to quantify the potential effect of future price decreases for these products, but it is almost certainly more significant than the example above.
At United Recovery Project, we offer intensive and unique programs for patients dealing with Kadian addiction. We offer various luxury treatment services to our patients including: drug detox, partial hospitalization programs, intensive outpatient programs & sober living and alumni program.
Throughout your stay at the facility, you will be monitored by a team of specialists to ensure you have a comfortable and safe recovery process. If you or someone you love is struggling with a Kadian addiction, do not hesitate to call us on: 855-580-4810 to start your drug addiction treatment.